Concepedia

Publication | Open Access

Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial

DOIFull Paper Access

219

Citations

22

References

2015

Year

Harold Bays, Daniel Gaudet, Robert Weiss, Juan Lima Ruiz, Gerald F. Watts, Ioanna Gouni‐Berthold, Jennifer G. Robinson, Jian Zhao, Corinne Hanotin, Stephen Donahue
The Journal of Clinical Endocrinology & Metabolism

Abstract

Adding alirocumab to atorvastatin provided significantly greater LDL-C reductions vs adding ezetimibe, doubling atorvastatin dose, or switching to rosuvastatin and enabled greater LDL-C goal achievement.

References

YearCitations

Page 1